Ting Ye

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Ulcerative Colitis

Multiple Myeloma

Oxide Nanoparticles

Cognitive Impairment

Top Venues

Expert opinion on drug safety

Metabolic brain disease

This page only lists publications with an associated author ORCID identifier.

Publications

Dongdong Yu, Ting Cheng, Tong Liu, Wenjun Xu, Dawei Liu, Jinzhi Dai, Shanshan Cai, Yuxiang Guan, Ting Ye, Xiaoyu Cheng
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Dongdong Yu, Ting Cheng, Tong Liu, Wenjun Xu, Dawei Liu, Jinzhi Dai, Shanshan Cai, Yuxiang Guan, Ting Ye, Xiaoyu Cheng
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Xiao-Yan Zhang, Xie Wang, Ting Ye, Nan Shao, Jie Wang, Biao Cai, Dao-Jun Xie
Network pharmacology-based approach to understand the effect and mechanism of chrysophanol against cognitive impairment in Wilson disease. Metabolic brain disease (2023)